QuantuMDx announces prototype handheld lab for rapid DNA
11 September 2014
Newcastle-based medical device developers QuantuMDx Group has
announced the successful production of their first fully-integrated
sample-to-result working prototype of Q-POC, a handheld lab that
delivers DNA-based medical diagnosis in minutes.
The Group believes the future of disease management and drug
resistance monitoring is networked geo-stamped data, a functionality
provided by the handheld Q-POC device. Rapid and low-cost testing
will enable continuous monitoring of disease and antimicrobial
resistance throughout populations, as well as surveillance for
emerging novel pathogen threats such as Ebola.
Thousands of Q-POC devices worldwide could use anonymized disease
data to create an early warning system which will contribute to the
prevention of pandemics, as well as the containment and management
of drug resistance. This global network of devices will enable true
personalized medicine at the individual level, and real-time public
health at the national or global level.
This prototype brings the Group one step closer to realizing
their vision, which they’ve named the Internet of Life. Q-POC
inventor Jonathan O’Halloran said, “The Internet revolutionised how
we share knowledge, and the Internet of Things is changing how we
interact with everyday objects. The Internet of Life will transform
how we monitor and manage disease.
With genetic data at their fingertips, frontline healthworkers
will be able to provide personalised healthcare, no matter where
they are; public health officials will have the information they
need to mobilize the right resources to the right place at the right
time; researchers will be better equipped to monitor the efficacy of
a disease intervention. Due for commercialisation in 2016, Q-POC is
the Bio-API that will make this possible by translating genetic code
QuantuMDx at TEDMED 2014
QuantuMDx is participating in The Hive, an informal social
environment featuring the innovative ideas that can transform health
and medicine in conjunction with TEDMED 2014, the annual
multidisciplinary gathering where leaders from all sectors of
society come together to explore the promise of technology and
potential of human achievement in health and medicine.
CEO Elaine Warburton OBE said, “It felt right to announce our
ground-breaking prototype at TEDMED, with this year’s theme of
unlocking imagination in health and medicine. Many said that our
vision for Q-POC was impossible, and yet here we are, with a
fully-integrated working prototype!”
"TEDMED is delighted to welcome this year's selection of leading
startups and entrepreneurs to The Hive, where we will be showcasing
the most exciting innovations in health and medicine," said TEDMED
COO and Partner Shirley Bergin. "All participants of The Hive will
help drive TEDMED's ongoing conversation about the best ways to
accelerate medical progress and create a healthier life worldwide."